Ethics approval and consent to participate
The Clinical Research Ethics Committee of the Valladolid East Health Area and the Spanish Agency for Medicine and Medical Devices (AEMPS) approved the study protocol, which followed European laws and the Declaration of Helsinki with its subsequent amendments. project title; ESTUDIO FASE I DE LA SEGURIDAD DE LAS CÉLULAS MADRE MESENQUIMALES MSV® EN INYECCIÓN INTRAVÍTREA PARA EL TRATAMIENTO DE PACIENTES CON NEUROPATÍA ÓPTICA ISQUÉMICA ANTERIOR NO ARTERÍTICA AGUDA. CÓDIGO PROMOTOR: IOBA-01-2016 Nº EUDRA: 2016-001032-35, approval number; CASVE 16-261, date of approval; 01-06-2016).